Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-05-30
2006-05-30
Morris, Patricia L. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S284000
Reexamination Certificate
active
07053095
ABSTRACT:
Novel triazole compounds, including derivatives thereof, to intermediates for their preparation, to pharmaceutical compositions containing them and to their medicinal use are described. The compounds of the present invention are potent inhibitors of transforming growth factor (“TGF”)-β signaling pathway. They are useful in the treatment of various TGF-related disease states including, for example, cancer and fibrotic diseases.
REFERENCES:
patent: 6436966 (2002-08-01), Ohkawa et al.
patent: 0149684 (1992-12-01), None
patent: 1205478 (2002-05-01), None
patent: 6058981 (1985-04-01), None
patent: 2000302680 (2000-10-01), None
patent: WO 9315071 (1993-08-01), None
patent: WO 9852937 (1998-11-01), None
patent: WO 9852941 (1998-11-01), None
patent: WO 0031063 (2000-06-01), None
patent: WO 0061576 (2000-10-01), None
patent: WO 0162756 (2001-08-01), None
patent: WO 0172737 (2001-10-01), None
patent: WO 0216359 (2002-02-01), None
patent: WO 0240468 (2002-05-01), None
patent: WO 0240476 (2002-05-01), None
patent: WO 0251442 (2002-07-01), None
patent: WO 0255077 (2002-07-01), None
patent: WO 0262753 (2002-08-01), None
patent: WO 0262775 (2002-08-01), None
patent: WO 0262776 (2002-08-01), None
patent: WO 0262787 (2002-08-01), None
patent: WO 0262793 (2002-08-01), None
patent: WO 0262794 (2002-08-01), None
patent: WO 0266462 (2002-08-01), None
patent: WO 02100433 (2002-12-01), None
patent: WO 0387304 (2003-10-01), None
patent: WO 0413125 (2004-02-01), None
patent: WO 0413135 (2004-02-01), None
Yang, Qiang, et al.,“The Reaction of Heteroaryl-Substituted Heterocyclic Ketene Aminals with 2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl Azide”, Heteroatom Chemistry (2002), 13(3), 242-247, XP009022047.
Liu, Bo, et al.,“The Reaction of Aroyl-Substituted Heterocyclic Ketene Aminals with Aryl Azides”, Heteroatom Chemistry (2000), 11(6), 387-391, XP009022048.
J. Singh, et al., “Successful Shape-Based Virtual Screening: The Discovery of a Potent Inhibitor of the Type I TGFβ Receptor Kinase (TβRI)”,Bioorganic&Medicinal Chemistry Letters, 13 (2003) 4355-4359.
Blumberg Laura C.
Munchhof Michael J.
Benson Gregg C.
Morris Patricia L.
Pfizer Inc.
Sisti Nicholas J.
LandOfFree
Triazole compounds as transforming growth factor (TGF)... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazole compounds as transforming growth factor (TGF)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazole compounds as transforming growth factor (TGF)... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3549301